Luxbright AB Net Assets
Luxbright AB net assets. Based on the latest financial reports, Luxbright AB (LXB) has net assets worth Skr23.41 Million SEK (≈ $2.52 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr32.25 Million ≈ $3.47 Million USD) and total liabilities (Skr8.85 Million ≈ $951.86K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Luxbright AB annual equity growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr23.41 Million |
| % of Total Assets | 72.58% |
| Annual Growth Rate | 27.42% |
| 5-Year Change | 30.37% |
| 10-Year Change | N/A |
| Growth Volatility | 106.69 |
Net Assets of Luxbright AB (2015–2025)
Net assets of Luxbright AB from 2015 to 2025. This chart illustrates how Luxbright AB's net assets have evolved over time, based on quarterly financial data. See Luxbright AB (LXB) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Luxbright AB (2015–2025)
The table below shows the annual net assets of Luxbright AB from 2015 to 2025. For live market cap and overall valuation, see Luxbright AB market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr26.89 Million ≈ $2.89 Million |
-21.35% |
| 2024-12-31 | Skr34.20 Million ≈ $3.68 Million |
+1.52% |
| 2023-12-31 | Skr33.69 Million ≈ $3.63 Million |
+20.89% |
| 2022-12-31 | Skr27.86 Million ≈ $3.00 Million |
+35.07% |
| 2021-12-31 | Skr20.63 Million ≈ $2.22 Million |
-46.60% |
| 2020-12-31 | Skr38.64 Million ≈ $4.16 Million |
+267.91% |
| 2019-12-31 | Skr10.50 Million ≈ $1.13 Million |
+52.20% |
| 2018-12-31 | Skr6.90 Million ≈ $742.52K |
+216.06% |
| 2017-12-31 | Skr-5.94 Million ≈ $-639.77K |
-791.08% |
| 2016-12-31 | Skr-667.16K ≈ $-71.80K |
-128.00% |
| 2015-12-31 | Skr2.38 Million ≈ $256.40K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Luxbright AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 17373596900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Luxbright AB Net Assets Breakdown (December 2025)
Luxbright AB net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr16.27 Million | 60.49% |
| Other Comprehensive Income | Skr6.37 Million | 23.70% |
| Other Components | Skr180.01 Million | 669.29% |
| Total Equity | Skr26.89 Million | 100.00% |
Luxbright AB Competitors by Market Cap
The table below lists competitors of Luxbright AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Grupo Televisa SAB DRC
BA:TV
|
$11.57 Million |
|
Ever Shine Textile Industry
JK:ESTI
|
$11.57 Million |
|
Schroder Asia Pacific Fund
LSE:SDP
|
$11.57 Million |
|
Golden Land Bhd
KLSE:7382
|
$11.58 Million |
|
Enero Group Ltd
AU:EGG
|
$11.56 Million |
|
Asuransi Kresna Mitra Tbk PT
JK:ASMI
|
$11.55 Million |
|
PATERSON RESOURCES LTD
F:U40
|
$11.54 Million |
|
Tscan Therapeutics Inc
NASDAQ:TCRX
|
$11.54 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Luxbright AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 34,197,000 to 26,895,000, a change of -7,302,000 (-21.4%).
- Net loss of 19,464,000 reduced equity.
- Other factors increased equity by 12,162,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-19.46 Million | -72.37% |
| Other Changes | Skr12.16 Million | +45.22% |
| Total Change | Skr- | -21.35% |
Book Value vs Market Value Analysis
This analysis compares Luxbright AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 28.89x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 81.79x to 28.89x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | Skr0.08 | Skr6.40 | x |
| 2016-12-31 | Skr-0.02 | Skr6.40 | x |
| 2017-12-31 | Skr-0.20 | Skr6.40 | x |
| 2018-12-31 | Skr0.24 | Skr6.40 | x |
| 2019-12-31 | Skr0.34 | Skr6.40 | x |
| 2020-12-31 | Skr1.27 | Skr6.40 | x |
| 2021-12-31 | Skr0.68 | Skr6.40 | x |
| 2022-12-31 | Skr0.71 | Skr6.40 | x |
| 2023-12-31 | Skr0.49 | Skr6.40 | x |
| 2024-12-31 | Skr0.33 | Skr6.40 | x |
| 2025-12-31 | Skr0.22 | Skr6.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Luxbright AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -72.37%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -170.51%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.46x
- Recent ROE (-72.37%) is below the historical average (-67.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -64.86% | -1818.60% | 0.02x | 2.02x | Skr-1.78 Million |
| 2016 | 0.00% | -427.73% | 0.06x | 0.00x | Skr-3.05 Million |
| 2017 | 0.00% | -566.98% | 0.13x | 0.00x | Skr-6.34 Million |
| 2018 | -177.67% | -875.41% | 0.09x | 2.18x | Skr-12.95 Million |
| 2019 | -101.46% | -1514.10% | 0.05x | 1.47x | Skr-11.70 Million |
| 2020 | -32.05% | -2015.86% | 0.01x | 1.14x | Skr-16.25 Million |
| 2021 | -87.73% | -2482.59% | 0.03x | 1.16x | Skr-20.16 Million |
| 2022 | -75.84% | -2603.66% | 0.03x | 1.12x | Skr-23.92 Million |
| 2023 | -75.33% | -2968.90% | 0.02x | 1.21x | Skr-28.74 Million |
| 2024 | -51.81% | -196.38% | 0.21x | 1.25x | Skr-21.14 Million |
| 2025 | -72.37% | -170.51% | 0.29x | 1.46x | Skr-22.15 Million |
Industry Comparison
This section compares Luxbright AB's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $471,003,634
- Average return on equity (ROE) among peers: -36.13%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Luxbright AB (LXB) | Skr23.41 Million | -64.86% | 0.38x | $11.56 Million |
| Acarix A/S (ACARIX) | $75.70 Million | -87.44% | 0.07x | $23.63 Million |
| Arcoma AB (ARCOMA) | $48.66 Million | 5.27% | 0.68x | $13.21 Million |
| Bactiguard Holding AB (publ) (BACTI-B) | $417.44 Million | -6.35% | 0.62x | $53.79 Million |
| BICO Group AB (BICO) | $3.01 Billion | -0.18% | 0.82x | $174.69 Million |
| Boule Diagnostics AB (BOUL) | $269.60 Million | -82.83% | 1.19x | $3.55 Million |
| CellaVision AB (CEVI) | $815.73 Million | 17.25% | 0.24x | $490.26 Million |
| Clinical Laserthermia Systems AB (publ) (CLS-B) | $10.83 Million | -64.40% | 0.20x | $9.27 Million |
| Chordate Medical Holding AB (CMH) | $25.64 Million | -77.06% | 0.22x | $29.05K |
| C-Rad AB (publ) (CRAD-B) | $35.05 Million | -30.59% | 0.38x | $82.28 Million |
| Duearity AB (DEAR) | $3.79 Million | -34.93% | 0.15x | $331.97K |
About Luxbright AB
Luxbright AB (publ), a technology company, develops, manufactures, and sells microfocus x-ray tubes and sources for industrial and non-destructive testing applications worldwide. It also provides Luxbright IX1, an integrated x-ray source product; and custom-made x-ray tubes. Luxbright AB (publ) was incorporated in 2012 and is headquartered in Västra Frölunda, Sweden.